언어 선택
무료 등록
제품 수집

PE-Labeled Monoclonal Anti-Human CD69 Antibody, Mouse IgG1 (3C5B7) (0.03% Proclin)

COADS MS
DS

사용자 리뷰
제품 번호/규격
가격
수량
FABm022-01-200tests (50tests X 4)
$200.00
ETA of in-stock products:2 business days
총 항목 수 제품 금액$ 0
신제품 제안
추가 항목 제안

제품 세부정보

  • Source

    PE-Labeled Monoclonal Anti-Human CD69 Antibody, Mouse IgG1 (3C5B7) is a mouse monoclonal antibody recombinantly expressed from Hybridoma.

  • Application

    Flow Cytometry (Evaluation of the expression of CD69 on Human cells).

  • Clone

    3C5B7

  • Species

    Mouse

  • Isotype

    Mouse IgG1 | Mouse Kappa

  • Specificity

    This product is a specific antibody specifically reacts with CD69 protein.

  • Reactivity

    Human

  • Immunogen

    Purified Human CD69 Protein

  • Conjugate

    PE

    Excitation Wavelength: 488 nm / 561 nm

    Emission Wavelength: 575 nm

  • Isotype Control

    The isotype control is sold separately; please refer to Cat. No. DNP-PM1 for product information.

  • Recommended Dilution

    1:20

  • Formulation

    Supplied as 0.2 μm-filtered solution in PBS (pH 7.4) containing 0.03% ProClin 300 and 0.2% BSA, with trehalose as protectant.

    Please contact us for customized product forms or formulations.

  • Storage

    Please protect from light and avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. Store at 2-8 °C for 12 months.

  • Shipping

    This product is supplied and shipped with blue ice, please inquire the shipping cost.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

고객님도 확인한 상품

데이터 표시

  • Bioactivity-FACS

    CD69 FACS

    Flow cytometric analysis of Jurkat staining with PE-Labeled Monoclonal Anti-Human CD69 Antibody, Mouse IgG1 (3C5B7) (Cat. No. FABm022-01) at 1:20 dilution (5 μL of the antibody stock solution corresponds to labeling of 1e6 cells in a final volume of 100 µL), compared with isotype control antibody. PE signal was used to evaluate the binding activity (QC tested).

    Protocol

사용자 리뷰
댓글 남기기

배경 소개

The activation of T lymphocytes involves a wide variety of cellular changes. Some of these changes are biochemical in nature, such as phosphatidylinositol catabolism and the elevationof cellular calcium. Others are genetic, involving the induction of specific gene expression. Among the constellation of genes induced following T cell activation are several cell surface molecules. One of the earliest of these to be expressed is CD69 (previously known as activation inducer molecule or AIM, EA-1, Leu-23,and MLR3). Within one to two h of activation, CD69 can be found on the cell surface, with expression persisting at least three days. Studies with monoclonal antibodies (MAb) to CD69 have shown that it is a costimulatory molecule for T cell proliferation. In addition, CD69 expression can be induced on most, if not all, cells of hematopoietic origin.

프론티어 진행

 
의약품 개발 진행
  • 영어 이름：

    Early activation antigen CD69

  • 카테고리：

  • 상장 의약품 수：

    0 상세

  • 임상 의약품 수：

    0 상세

  • 최고 개발 단계：

    Preclinical

연락하기
신약 후보물질 라이선싱
더 많이 알아보기
  • 기본 제품 정보
  • 제품 세부정보
  • 고객님도 확인한 상품
  • 데이터 표시
  • 사용자 리뷰
  • 배경
공유하기:

[North America]: +1 800-810-0816 [Switzerland]: +41 800 040 012 [Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA [Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland

Email：order@acrobiosystems.com

Copyright © 2025 ACROBiosystems. All Rights Reserved

참여하기법적 규정사이트맵개인정보 정책약관 및 조건
웹사이트 피드백
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

이메일
order.kr@acrobiosystems.com

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호